FDA Concludes Actos Is Linked To Bladder Cancer After Literature Review

(December 13, 2016, 1:31 PM EST) -- SILVER SPRING, Md. — The Food and Drug Administration on Dec. 12 said an updated review of medical studies has led it to conclude that the diabetes drug Actos may be...
To view the full article, register now.